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Abstract - α-(Trifluoromethyl)styrenes bearing a nucleophilic oxygen 
or sulfur atom tethered by a methylene or methyne unit at the ortho 
carbon were prepared by the coupling reaction of 2-bromo-3,3,3-
trifluoropropene with aryl iodides via (3,3,3-trifluoroprop-1-en-2-
yl)boronic acid. The styrenes thus obtained readily undergo an 
intramolecular nucleophilic addition or substitution (SN2′-type) of the 
oxygen and sulfur under basic conditions, leading to 4-trifluoromethyl- 
or 4-difluoromethylene-substituted isochromanes and 
isothiochromanes, respectively. 
 
INTRODUCTION 
Isochromane (3,4-dihydro-1H-2-benzopyran)1 and isothiochromane (3,4-dihydro-1H-2-benzothiopyran)2 
derivatives constitute an important class of natural and synthetic compounds. Because they exhibit a wide 
variety of biological activities, iso(thio)chromane skeletons are frequently found in the structures of drugs 
 
 
 
and drug candidates. Moreover, they are structural analogues of tetrahydroisoquinolines, which are 
widespread in the alkaloid family.3 Hence, there have been many reports on the use of iso(thio)chromanes 
as starting materials or intermediates for the synthesis of medicinal and agrochemical agents.4 
While the synthesis of iso(thio)chromanes has been extensively studied,1,2,5 a quite limited number of 
reports have appeared on the synthesis of their partially fluorinated counterparts.6 The introduction of 
fluorocarbon substituents into heterocycles has come into wide use as one of the most efficient methods 
for modification of biological activity, as well as of physical and chemical properties.7,8 In particular, the 
incorporation of a trifluoromethyl (CF3) group into organic molecules increases lipophilicity and affects 
electron density.9 An exo-difluoromethylene (=CF2) group acts as a reactive site toward nucleophiles,10,11 
and its reduction provides a difluoromethyl (CHF2) group,12 which raises lipophilicity and functions as a 
hydrogen-bond donor without nucleophilicity.13 Thus, the development of a synthetic method for 
iso(thio)chromanes with these fluorinated one-carbon units is a highly desirable goal. 
α-(Trifluoromethyl)styrenes are susceptible to nucleophilic attack, because of the electron-withdrawing 
trifluoromethyl group. Utilizing this reactivity, we have recently found that the (trifluoromethyl)styrenes 
with a nitrogen functionality readily undergo an intramolecular addition or SN2′-type reaction, depending 
on conditions with or without a proton source. These reactions provided quinoline and isoquinoline 
derivatives bearing a fluorinated one-carbon unit such as a CF3, CHF2, or =CF2 group.14 
In a continuation of our research on the cyclizations of 2-trifluoromethyl-1-alkenes,14,15 we sought to 
apply the intramolecular addition and substitution concept to the construction of 6-membered oxygen- or 
sulfur-containing heterocycles, isochromane and isothiochromane derivatives. On the basis of these 
considerations, α-(trifluoromethyl)styrene derivatives were designed to bear a nucleophilic oxygen or a 
sulfur atom tethered by a methylene or methyne unit at the ortho carbon. They were subjected to the ring-
forming reactions in a 6-endo-trig fashion under basic conditions. Herein we wish to report the results of 
our studies on the synthesis of 4-trifluoromethyl- or 4-difluoromethylene-substituted isochromanes and 
isothiochromanes. 
 
RESULTS AND DISCUSSION 
Preparation of α-(Trifluoromethyl)styrenes Bearing a Nucleophilic Oxygen or Sulfur Atom 
The cyclization precursors, o-substituted α-(trifluoromethyl)styrenes, were easily prepared by the 
Suzuki–Miyaura cross-coupling reaction of aryl iodides with (3,3,3-trifluoroprop-1-en-2-yl)boronic acid 
 
 
 
(2) that was prepared from 2-bromo-3,3,3-trifluoropropene (1), according to a modified literature 
procedure (Scheme 1).14a,16 (Trifluoromethyl)styrene 3a bearing a hydroxymethyl group at the ortho 
position, precursors of isochromanes, was successfully obtained in 88% yield via the coupling of 2 with 
o-iodobenzyl alcohol (Scheme 1, route A). Alcohols 3 were also obtained via another route, which allows 
the introduction of a substituent (R) on the benzylic carbon (route B). The coupling of 2 with o-
iodobenzaldehyde afforded (trifluoromethyl)styrene 4 bearing an o-formyl group in 81% yield. The 
addition of nucleophiles such as Grignard reagents to 4 selectively occurred at the formyl carbon to 
provide 3b and 3c.  
As sulfur-containing substrates for the synthesis of isothiochromanes, thioacetates 6 were readily 
prepared from alcohols 3 via the corresponding mesylates 5 by the introduction of an acetylthio (AcS) 
group at the benzylic position on treatment with the 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) salt of 
ethanethioic S-acid (Scheme 1, route C). 
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equiv), Pd(PPh3)4 (3a: 0.01 equiv; 4: 0.005 equiv), 1 M Na2CO3 aq (3a: 0.6 equiv; 4: 0.3 equiv), toluene–
MeOH (5:1), 70 °C, 3a: 16 h; 4: 32 h; iv, 3b: n-BuMgBr (1.2 equiv), Et2O, –78 °C, 0.5 h then rt, 3 h; 3c: 
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Scheme 1. Preparation of α-(trifluoromethyl)styrenes functionalized at the ortho position. 
 
Cyclization of α-(Trifluoromethyl)styrenes Bearing a Nucleophilic Oxygen or Sulfur Atom 
We first examined the cyclization of (trifluoromethyl)styrenes 3 with a nucleophilic oxygen as precursors 
of isochromanes. Intramolecular addition of 3a was attempted under basic conditions with a proton 
source to trap the intermediary trifluoromethylated carbanion. Treatment of 3a with KOH (1.5 equiv) in 
ethylene glycol (ethane-1,2-diol) gave the desired cyclic product 7a in 37% yield, whereas the addition 
was more successfully effected by the use of DBU (1.1 equiv) in diglyme [bis(2-methoxyethyl) ether] at 
120 °C (Table 1, Entry 1), where the hydroxy group of 3a and/or DBU•H+ acted as a proton donor. 4-
Trifluoromethylated isochromane 7a was obtained in 82% yield without formation of a substitution 
product 8a (vide infra). In the case of secondary alcohols 3b,c, ring closure also occurred under similar 
conditions, leading to 1,4-disubstituted isochromanes 7b,c in 72 and 86% yields with 87:13 and 57:43 
diastereomer ratios, respectively (Entries 2 and 3). 
Chromane precursors 3 were next subjected to basic conditions in the absence of a proton source to 
attempt intramolecular substitution, leading to 4-difluoromethylenated isochromanes 8. Treatment with 
NaH in dimethylformamide (DMF) mainly caused decomposition of 3a and afforded the expected SN2′-
type product 8a only in 10% yield along with 7a in 20% yield. After screening of basic conditions, we 
found that treatment with K3PO4 (2.0 equiv) in DMF improved the yield of 8a to 38% with the 
accompanying formation of 7a in 11% yield (Entry 4). 
 
Table 1. Synthesis of 4-trifluoromethylated and 4-difluoromethylenated isochromanes. 
 
 
 
 
HO
CF3
O
CF2
O
CF3
Base
3 87
R RR
87
Conditions
DBU (1.1) 082
072 (87 : 13)b
Entry
1
2
R (3)
n-Bu (3b)
H (3a)
38114 H (3a)
086 (57 : 43)b3 Ph (3c)
8 (69 : 31)b5 Ph (3c)
Base (equiv) Solvent
Diglyme 120 ºC, 48 h
DBU (1.5) Diglyme 120 ºC, 96 h
DBU (1.1) Diglyme 120 ºC, 24 h
K3PO4 (2.0) 120 ºC, 3 hDMF
K3PO4 (2.0) 120 ºC, 6 hDMF
Yield (%)a
43
and/or
 
  aIsolated yield. bDiastereomer ratio determined by 19F NMR measurement. 
 
We then tried the cyclizations via addition or substitution using sulfur nucleophiles, which would provide 
isothiochromanes. When thioacetates 6a,b were treated with K2CO3 (1.1 equiv) in MeOH, the 
deacetylation of 6 occurred to generate the corresponding thiolates, whose intramolecular addition readily 
proceeded in the presence of a proton source. The desired products, 4-trifluoromethylated 
isothiochromanes 9a,b were obtained in 92% yield and 80% yield with 57:43 diastereomer ratio, 
respectively (Table 2, Entries 1 and 2). In contrast, treatment of 6a,b with sodium methoxide (2.0–3.0 
equiv) in tetrahydrofuran (THF) promoted deacetylation followed by SN2′-type reaction instead of 
addition, which is due to the aprotic conditions. The two successive processes provided 4-
difluoromethylenated isothiochromanes 10a,b in 76% and 73% yields, respectively (Entries 3 and 4). 
 
Table 2. Synthesis of 4-trifluoromethylated and 4-difluoromethylenated isothiochromanes. 
 
 
 
 
AcS
CF3
S
CF2
Base
6 9 10
109
492
380 (57:43)b
R
Entry
1
2
R (6)
n-Bu (6b)
H (6a)
7610
730
3
4 n-Bu (6b)
H (6a)
S
CF3
Conditions
K2CO3 (1.1)
Base (equiv) Solvent
0 ºC, 4 h
K2CO3 (1.1) reflux, 2 h
NaOMe (2.0) 0 ºC, 0.5 h, then rt, 3 hTHF
NaOMe (3.0) reflux, 19 hTHF
MeOH
MeOH
Yield (%)a
R R
and/or
 
  aIsolated yield. bDiastereomer ratio determined by 19F NMR measurement. 
 
In conclusion, the above results show that our intramolecular addition and substitution concept in 2-
trifluoromethyl-1-alkenes can be successfully applied to the construction of 6-membered oxygen- or 
sulfur-containig heterocycles as well as nitrogen-containing heterocycles. o-Substituted α-
(trifluoromethyl)styrenes, prepared from 2-bromo-3,3,3-trifluoro-1-propene and aryl iodides, readily 
undergo 6-endo ring closure via addition or substitution, depending on the reaction conditions. These 
reactions provide a facile method for the construction of selectively trifluoromethylated and 
difluoromethylenated benzo(thio)pyran frameworks. 
 
EXPERIMENTAL 
IR spectra were recorded by ATR (attenuated total reflectance) method. NMR spectra were recorded in 
CDCl3 at 500 MHz (1H NMR), 126 MHz (13C NMR), and 470 MHz (19F NMR). Chemical shift values 
were given in ppm relative to internal Me4Si (for 1H NMR: δ 0.00), CDCl3 (for 13C NMR: δ 77.0), and 
C6F6 (for 19F NMR: δF 0.0). Column chromatography and preparative thin-layer chromatography (PTLC) 
were performed on silica gel. Unless otherwise noted, all reactions were conducted under nitrogen. 
Toluene, DMF, CH2Cl2, THF, and diethyl ether (Et2O) were dried by passing over a column of activated 
alumina (A-2, Purity) followed by a column of Q-5 scavenger (Engelhard). MeOH was distilled from Mg, 
and stored over molecular sieves 3Å. Ethylene glycol and diglyme were distilled from MgSO4 and CaH2, 
respectively, and then stored over molecular sieves 4Å. 
 
 
 
 
[2-(3,3,3-Trifluoroprop-1-en-2-yl)phenyl]methanol (3a): To a magnesium turnings (571 m g, 23.4 
mmol) and trimethylborate (6.51 mL, 58.5 mmol) in THF (40 mL) was added 2-bromo-3,3,3-
trifluoropropene (2.00 mL, 19.5 mmol) in THF (5 mL) over 1 h at 0 °C. The reaction mixture was stirred 
at 0 °C for 3 h. The reaction mixture was quenched with HCl (20 mL of 6 M aqueous solution), and 
organic materials were extracted three times each with Et2O. The combined extracts were washed with 
brine and then dried over MgSO4. Removal of the solvent under reduced pressure gave the residue, crude 
1-(trifluoromethyl)vinylboronic acid (2) [19F NMR (CDCl3) δF 98.3 (s)], which was immediately used 
without purification in the following palladium-catalyzed coupling reaction with iodoarenes. The mixture 
of the crude boronic acid 2, 2-iodophenylmethanol (2.62 g, 11.2 mmol), sodium carbonate (12 mL of 1.0 
M aqueous solution), Pd(PPh3)4 (259 mg, 0.224 mmol) in toluene–MeOH (140 mL, 5:1) was stirred at 
70 °C for 16 h. The reaction was quenched with phosphate buffer (pH 7). The mixture was extracted with 
ethyl acetate three times. The combined extracts were washed with brine and dried over Na2SO4. After 
removal of the solvent under reduced pressure, the residue was purified by column chromatography 
(hexane–AcOEt 3:1) to give 3a (2.00 g, 88%) as a colorless oil. 1H NMR (500 MHz, CDCl3, δ): 4.67 (s, 
2H), 5.60 (q, JHF = 1.2 Hz, 1H), 6.15 (q, JHF = 1.4 Hz, 1H), 7.26 (d, J = 7.6 Hz, 1H), 7.32 (dd, J = 7.6, 7.6 
Hz, 1H), 7.43 (dd, J = 7.6, 7.6 Hz, 1H), 7.57 (d, J = 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): 62.7, 
122.8 (q, JCF = 274 Hz), 123.5 (q, JCF = 5 Hz), 127.5, 128.4, 129.3, 129.8, 132.4, 136.9 (q, JCF = 31 Hz), 
139.4. 19F NMR (470 MHz, CDCl3, δF): 94.7 (s). IR (neat): 3330, 1342, 1217, 1169, 1115, 1072, 769 cm-1. 
Anal. Calcd for C10H9OF3: C, 59.41; H, 4.49. Found: C, 59.21; H, 4.58. 
2-(3,3,3-Trifluoroprop-1-en-2-yl)benzaldehyde (4): Compound 4 was prepared by the method 
described for 3a. Purification by column chromatography (hexane–AcOEt 5:1) gave 4 (81%) as a 
colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 5.62 (q, JHF = 1.3 Hz, 1H), 6.29 (q, JHF = 1.3 Hz, 1H), 
7.41 (d, J = 7.6 Hz, 1H), 7.56 (dd, J = 7.6, 7.6 Hz, 1H), 7.63 (dd, J = 7.6, 7.6 Hz, 1H), 8.01 (d, J = 7.6 Hz, 
1H), 10.1 (s, 1H). 13C NMR (126 MHz, CDCl3, δ): 122.4 (q, JCF = 274 Hz), 125.1 (q, JCF = 5 Hz), 128.4, 
129.5, 130.7, 133.6, 134.8, 135.4 (q, JCF = 32 Hz), 136.6, 190.8. 19F NMR (470 MHz, CDCl3, δF): 94.8 (s). 
IR (neat): 2858, 1701, 1599, 1346, 1173, 1126, 962 cm-1. Anal. Calcd for C10H7OF3: C, 60.01; H, 3.53. 
Found: C, 60.03; H, 3.66. 
1-[2-(3,3,3-Trifluoroprop-1-en-2-yl)phenyl]pentan-1-ol (3b): To a solution of 4 (1.02 g, 5.09 mmol) in 
Et2O (45 ml) was added butylmagnesium bromide (3.06 ml, 2.0 M in Et2O, 6.12 mmol) at –78 °C. The 
 
 
 
reaction mixture was stirred at –78 °C for 30 min and at room temperature for an additional 3 h. Then, 
phosphate buffer (pH 7) was added to quench the reaction. Organic materials were extracted with Et2O 
three times. The combined extracts were washed with brine and dried over Na2SO4. After removal of the 
solvent under reduced pressure, the residue was purified by column chromatography (hexane–AcOEt 3:1) 
to give 3b (1.12 g, 85%) as a colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 0.88 (t, J = 7.2 Hz, 3H), 
1.21–1.45 (m, 4 H), 1.62–1.69 (m, 1H), 1.76–1.83 (m, 2H), 4.79 (dd, J = 8.3, 5.0 Hz, 1H), 5.52 (q, JHF = 
1.2 Hz, 1H), 6.14 (q, JHF = 1.4 Hz, 1H), 7.19 (d, J = 7.6 Hz, 1H), 7.28 (dd, J = 7.6, 7.6 Hz, 1H), 7.43 (dd, 
J = 7.6, 7.6 Hz, 1H), 7.60 (d, J = 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): 13.9, 22.5, 28.2, 38.3, 70.6, 
122.8 (q, JCF = 274 Hz), 123.5 (q, JCF = 5 Hz), 126.2, 127.2, 129.5, 129.8, 131.8, 137.5 (q, JCF = 31 Hz), 
143.8. 19F NMR (470 MHz, CDCl3, δF): 94.5 (s). IR (neat): 2933, 2862, 1340, 1167, 1124, 1095, 953, 762, 
631 cm-1. Anal. Calcd for C14H17OF3: C, 65.10; H, 6.63. Found: C, 65.45; H, 7.00. 
Phenyl[2-(3,3,3-trifluoroprop-1-en-2-yl)phenyl]methanol (3c): Compound 3c was prepared by the 
method described for 3b. Purification by column chromatography (hexane–AcOEt 5:1) gave 4 (91%) as a 
white solid. 1H NMR (500 MHz, CDCl3, δ): 2.12 (d, J = 3.8 Hz, 1H), 5.42 (q, JHF = 1.1 Hz, 1H), 5.98 (d, 
J = 3.8 Hz, 1H), 6.12 (q, JHF = 1.4 Hz, 1H), 7.24–7.28 (m, 2H), 7.29–7.35 (m, 5H), 7.40 (dd, J = 7.6, 7.6 
Hz, 1H), 7.51 (d, J = 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): 72.5, 122.9 (q, JCF = 274 Hz), 124.2 (q, 
JCF = 5 Hz), 126.6, 127.5, 127.5, 127.9, 128.4, 129.4, 129.9, 132.5, 136.9 (q, JCF = 31 Hz), 142.5, 143.4. 
19F NMR (470 MHz, CDCl3, δF): 94.7 (s). IR (neat): 3334, 2921, 1342, 1403, 1169, 1122, 1016, 700 cm-1. 
Anal. Calcd for C16H13OF3: C, 69.06; H, 4.71. Found: C, 68.92; H, 4.78. 
S-[2-(3,3,3-Trifluoroprop-1-en-2-yl)phenyl]methyl ethanethioate (6a): Compound 6a was prepared by 
the method described for 6b (vide infra). Purification by PTLC (hexane–AcOEt 5:1) gave 6a (85%) as a 
colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 2.34 (s, 3H), 4.13 (s, 2H), 5.59 (q, JHF = 1.3 Hz, 1H), 
6.17 (q, JHF = 1.4 Hz, 1H), 7.22 (d, J = 7.6 Hz, 1H), 7.27 (dd, J = 7.6, 7.6 Hz, 1H), 7.34 (dd, J = 7.6, 7.6 
Hz, 1H), 7.43 (d, J = 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): 30.2, 30.8, 122.8 (q, JCF = 274 Hz), 
123.9 (q, JCF = 5 Hz), 127.2, 129.4, 130.0, 130.3, 133.3, 136.5, 137.0 (q, J = 31 Hz), 194.8. 19F NMR (470 
MHz, CDCl3, δF): 94.6 (s). IR (neat): 2252, 1684, 1344, 1203, 1132, 903, 721, 650 cm-1. Anal. Calcd for 
C12H11OF3S: C, 55.38; H, 4.26. Found: C, 55.49; H, 4.43. 
S-1-[2-(3,3,3-Trifluoroprop-1-en-2-yl)phenyl]pentyl ethanethioate (6b): To a solution of 3b (615 mg, 
2.38 mmol) and triethylamine (0.50 mL, 3.6 mmol) in CH2Cl2 (11 ml) was added methanesulfonyl 
chloride (0.22 mL, 2.9 mmol) at 0 °C. After the reaction mixture was stirred at 0 °C for 2 h, saturated 
 
 
 
aqueous NH4Cl was added to quench the reaction. The organic layer was washed with brine and dried 
over MgSO4. Removal of the solvent under reduced pressure gave the residue, crude mesylate 5b, which 
was used without purification in the following substitution reaction with ethanethioic S-acid. To a 
solution of DBU (1.04 mL, 7.0 mmol) in DMF (3.3 ml) was added ethanethioic S-acid (0.50 mL, 7.1 
mmol) dropwise at room temperature. The crude mesylate 5b in DMF (6.6 ml) was added, and the 
mixture was stirred at room temperature for 20 h. The reaction was quenched with saturated aqueous 
NH4Cl. After water was added, organic materials were extracted with AcOEt three times. The combined 
extracts were washed with brine and dried over Na2SO4. After removal of the solvent under reduced 
pressure, the residue was purified by column chromatography (hexane–AcOEt 5:1) to give 6b (600 mg, 
82%) as a colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 0.84 (t, J = 7.2 Hz, 3H), 1.16–1.18 (m, 1H), 
1.26–1.31 (m, 3 H), 1.87–1.93 (m, 2H), 2.28 (s, 3H), 4.76 (t, J = 7.6 Hz, 1H), 5.59 (q, JHF = 1.1 Hz, 1H), 
6.19 (q, JHF = 1.3 Hz, 1H), 7.22–7.27 (m, 2H), 7.36–7.37 (m, 2H). 13C NMR (126 MHz, CDCl3, δ): 13.8, 
22.4, 29.4, 30.3, 37.1, 44.6, 122.9 (q, JCF = 274 Hz), 124.1 (q, JCF = 5 Hz), 126.8, 127.8, 129.3, 130.0, 
132.6, 136.6 (q, JCF = 31 Hz), 140.6, 194.2. 19F NMR (470 MHz, CDCl3, δF): 95.0 (s). IR (neat): 2931, 
2862, 1691, 1402, 1342, 1201, 1167, 1092, 1068, 953, 629 cm-1. Anal. Calcd for C16H19OF3S: C, 60.74; H, 
6.05. Found: C, 60.51; H, 6.14. 
4-Trifluoromethyl-3,4-dihydro-1H-2-benzopyran (7a): To a solution of 3a (51 mg, 0.25 mmol) in 
diglyme (2.5 mL) was added DBU (42 µL, 0.28 mmol). After the reaction mixture was heated at 120 °C 
for 48 h, phosphate buffer (pH 7) was added to quench the reaction. Organic materials were extracted 
with Et2O three times. The combined extracts were washed with brine and dried over Na2SO4. After 
removal of the solvent under reduced pressure, the residue was purified by PTLC (pentane–Et2O 5:1) to 
give 7a (42 mg, 82%) as a colorless crystal. 1H NMR (500 MHz, CDCl3, δ): 3.42 (qm, JHF = 9.3 Hz, 1H), 
3.92 (dm, J = 12.3 Hz, 1H), 4.41 (dd, J = 12.3, 2.3 Hz, 1H), 4.76 (d, J = 15.2 Hz, 1H), 4.87 (d, J = 15.2 
Hz, 1H), 7.07 (d, J = 7.6 Hz, 1H), 7.26 (dd, J = 7.6, 7.6 Hz, 1H), 7.32 (dd, J = 7.6, 7.6 Hz, 1H), 7.37 (d, J 
= 7.6 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): 41.1 (q, JCF = 26 Hz), 63.8 (q, JCF = 3 Hz), 67.7, 124.7, 
126.1 (d, JCF = 1 Hz), 126.2 (q, JCF = 281 Hz), 126.8, 128.3, 130.2, 135.8. 19F NMR (470 MHz, CDCl3, 
δF): 93.7 (d, JFH = 9 Hz). IR (neat): 2871, 1734, 1495, 1456, 1350, 1269, 1230, 1153, 1108, 995, 912, 742 
cm-1. Anal. Calcd for C10H9OF3: C, 59.41; H, 4.49. Found: C, 59.28; H, 4.54. 
1-Butyl-4-trifluoromethyl-3,4-dihydro-1H-2-benzopyran (7b): Compound 7b was prepared by the 
method described for 7a. Purification by PTLC (pentane–Et2O 10:1) gave 7b (72%; 87:13 diastereomer 
 
 
 
ratio) as a colorless liquid. 1H NMR (500 MHz, CDCl3, δ): (major) 0.90 (t, J = 7.2 Hz, 3H), 1.28–1.46 (m, 
4H), 1.80–1.88 (m, 1H), 1.94–2.01 (m, 1H), 3.26 (qd, JHF = 9.2, 3.6 Hz, 1H), 3.83 (ddq, J = 12.3, 3.6, 1.8 
Hz, 1H), 4.47 (d, J = 12.3 Hz, 1H), 4.74 (dd, J = 7.6, 2.7 Hz, 1H), 7.18 (d, J = 7.6 Hz, 1H), 7.23–7.26 (m, 
1H), 7.32–7.35 (m, 2H); (minor) 0.94 (t, J = 7.2 Hz, 3H), 1.32–1.55 (m, 4H), 1.70–1.77 (m, 1H), 1.81–
1.89 (m, 1H), 3.38–3.45 (m, 1H), 4.12 (d, J = 4.0 Hz, 2H), 4.79 (dd, J = 10.1, 3.2 Hz, 1H), 7.12 (d, J = 
7.6 Hz, 1H), 7.23–7.26 (m, 1H), 7.31 (dd, J = 7.6, 7.6 Hz, 1H), 7.36 (J = 7.6 Hz, 1H). 13C NMR (126 
MHz, CDCl3, δ): (major) 14.0, 22.8, 26.8, 35.4, 41.8 (q, JCF = 26 Hz), 62.8 (q, JCF = 3 Hz), 76.3, 124.9, 
126.2 (q, JCF = 281 Hz), 126.4, 126.9 (q, JCF = 2 Hz), 128.5, 130.5, 139.5; (minor) 14.0, 22.5, 28.1, 34.8, 
41.5 (q, JCF = 26 Hz), 58.8 (q, JCF = 3 Hz), 75.0, 125.5, 126.3 (q, JCF = 281 Hz), 126.4 (q, JCF = 2 Hz), 
126.6, 128.1, 129.6, 139.8. 19F NMR (470 MHz, CDCl3, δF): (major) 93.9 (d, JFH = 9 Hz); (minor) 93.8 (d, 
JFH = 9 Hz). IR (neat) 2956, 2931, 1250, 1155, 1119, 750, 620 cm-1. Anal. Calcd for C14H17OF3: C, 65.10; 
H, 6.63. Found: C, 65.02; H, 6.77. 
1-Phenyl-4-trifluoromethyl-3,4-dihydro-1H-2-benzopyran (7c): Compound 7c was prepared by the 
method described for 7a. Purification by PTLC (pentane–Et2O 5:1) gave 7b (86%; 57:43 diastereomer 
ratio) as a colorless crystal. 
1H NMR (500 MHz, CDCl3, δ): (major) 3.40 (qd, JHF = 9.1, 3.6 Hz, 1H), 4.07 (ddq, J = 12.4, 3.6, 1.8 Hz, 
1H), 4.59 (d, J = 12.4 Hz, 1H), 5.66 (s, 1H), 6.79 (d, J = 7.5 Hz, 1H), 7.21 (dd, J = 7.5, 7.5 Hz, 1H), 7.25 
(dd, J = 7.5, 7.5 Hz, 1H), 7.34–7.37 (m, 5H), 7.39 (d, J = 7.5 Hz, 1H); (minor) 3.52–3.57 (m, 1H), 4.05–
4.12 (m, 2H), 5.88 (s, 1H), 6.93 (d, J = 7.4 Hz, 1H), 7.19–7.22 (m, 2H), 7.27–7.38 (m, 5H), 7.47 (d, J = 
7.4 Hz, 1H). 13C NMR (126 MHz, CDCl3, δ): (major) 41.5 (q, JCF = 26 Hz), 63.6 (q, JCF = 3 Hz), 80.5, 
126.2 (q, JCF = 281 Hz), 126.4 (q, JCF = 2 Hz), 126.9, 127.1, 128.4, 128.5, 128.6, 128.9, 130.2, 138.9, 
141.1; (minor) 41.3 (q, JCF = 26 Hz), 59.4 (q, JCF = 3 Hz), 77.8, 126.3 (q, JCF = 281 Hz), 127.2 (q, JCF = 2 
Hz), 127.2, 127.5, 127.9, 128.3, 128.4, 129.1, 129.6, 137.1, 140.9. 19F NMR (470 MHz, CDCl3, δF): 
(major) 93.9 (d, JFH = 9 Hz); (minor) 93.8 (d, JFH = 9 Hz). IR (neat): 3064, 3031, 2870, 1455, 1355, 1243, 
1155, 999, 747, 700 cm-1. Anal. Calcd for C16H13OF3: C, 69.06; H, 4.71. Found: C, 69.08; H, 4.94. 
4-Difluoromethylene-3,4-dihydro-1H-2-benzopyran (8a): Compound 8a was prepared by the method 
described for 8c (vide infra). Purification by PTLC (pentane–Et2O 5:1) gave 8a (38%) as a colorless 
liquid. 1H NMR (500 MHz, CDCl3, δ): 4.50 (dd, JHF = 2.7, 2.7 Hz, 2H), 4.79 (s, 2H), 7.05 (d, J = 7.5 Hz, 
1H), 7.21 (dd, J = 7.5, 7.5 Hz, 1H), 7.27 (dd, J = 7.5, 7.5 Hz, 1H), 7.61 (d, J = 7.5 Hz, 1H). 13C NMR 
(126 MHz, CDCl3, δ): 63.2 (dd, JCF = 4, 4 Hz), 68.9, 85.7 (dd, JCF = 20, 13 Hz), 124.7, 125.7 (d, JCF = 3 
 
 
 
Hz), 126.6 (dd, JCF = 10, 5 Hz), 127.0 (dd, JCF = 2, 2 Hz), 127.3, 134.1 (dd, JCF = 5, 3 Hz), 152.3 (dd, JCF 
= 296, 291 Hz). 19F NMR (470 MHz, CDCl3, δF): 75.6 (d, JFF = 41 Hz, 1F), 75.5 (d, JFF = 41 Hz, 1F). IR 
(neat): 2958, 2846, 1722, 1329, 1261, 1236, 1086, 1053, 760, 737 cm-1. Anal. Calcd for C10H8OF2: C, 
65.93; H, 4.43. Found: C, 66.07; H, 4.59. 
4-Difluoromethylene-1-phenyl-3,4-dihydro-1H-2-benzopyran (8c): To a solution of 8c (53 mg, 0.19 
mmol) in DMF (2.0 mL) was added K3PO4 (81 mg, 0.38 mmol) at room temperature. After the reaction 
mixture was stirred at 120 °C for 6 h, phosphate buffer (pH 7) was added to quench the reaction. Organic 
materials were extracted with Et2O three times. The combined extracts were washed with brine and dried 
over Na2SO4. After removal of the solvent under reduced pressure, the residue was purified by PTLC 
(pentane–Et2O 5:1) to give 8c (21 mg, 43%) as a colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 4.43 
(ddd, J = 13.2 Hz, JHF = 3.6, 3.6 Hz, 1H), 4.63 (dd, J = 13.2 Hz, JHF = 2.6 Hz, 1H), 5.76 (s, 1H), 6.81 (d, J 
= 7.6 Hz, 1H), 7.13 (dd, J = 7.6, 7.6 Hz, 1H), 7.24–7.39 (m, 6H), 7.66 (d, J = 7.6 Hz, 1H). 13C NMR (126 
MHz, CDCl3, δ): 61.0 (dd, JCF = 4, 4 Hz), 80.0, 86.0 (dd, JCF = 24, 8 Hz), 126.4 (dd, JCF = 4, 2 Hz), 126.5 
(dd, JCF = 14, 2 Hz), 126.9 (dd, JCF = 2, 2 Hz), 127.1, 127.5, 128.4, 128.5, 128.8, 136.5 (dd, JCF = 6, 2 Hz), 
140.7, 152.2 (dd, JCF = 300, 287 Hz). 19F NMR (470 MHz, CDCl3, δF): 75.5 (d, JFF = 41 Hz, 1F), 75.9 (d, 
JFF = 41 Hz, 1F). IR (neat): 3066, 3032, 2927, 2854, 1732, 1718, 1238, 760, 700 cm-1. Anal. Calcd for 
C16H12OF2: C, 74.41; H, 4.68. Found: C, 74.42; H, 4.91. 
4-Trifluoromethyl-3,4-dihydro-1H-2-benzothiopyran (9a): To a solution of 6a (44 mg, 0.17 mmol) in 
MeOH (1.7 mL) was added K2CO3 (26 mg, 0.19 mmol) at 0 °C. After the reaction mixture was stirred at 
0 °C for 4 h, phosphate buffer (pH 7) was added to quench the reaction. Organic materials were extracted 
with Et2O three times. The combined extracts were washed with brine and dried over MgSO4. After 
removal of the solvent under reduced pressure, the residue was purified by PTLC (pentane–Et2O 20:1) to 
give 7a (34 mg, 92%) as a colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 3.11 (dd, J = 13.6, 6.4 Hz, 
1H), 3.17 (dd, J = 13.6, 5.8 Hz, 1H), 3.73–3.81 (m, 1H), 3.78 (s, 2H), 7.17–7.19 (m, 1H), 7.24–7.29 (m, 
2H), 7.37–7.38 (m, 1H). 13C NMR (126 MHz, CDCl3, δ): 25.6 (q, JCF = 3 Hz), 30.0, 42.9 (q, JCF = 26 Hz), 
126.4 (q, JCF = 282 Hz), 127.1, 127.9, 128.6, 129.5 (q, JCF = 1 Hz), 130.4 (q, JCF = 2 Hz), 136.1. 19F NMR 
(470 MHz, CDCl3, δF): 94.6 (d, JFH = 9 Hz). IR (neat): 3064, 2921, 1496, 1448, 1340, 1270, 1241, 1151, 
1103, 950, 763, 739 cm-1. Anal. Calcd for C10H9F3S: C, 55.03; H, 4.16. Found: C, 55.17; H, 4.32. 
 
 
 
1-Butyl-4-trifluoromethyl-3,4-dihydro-1H-2-benzothiopyran (9b): Compound 9b was prepared by the 
method described for 9a. Purification by PTLC (pentane–Et2O 30:1) gave 9b (80%; 59:41 diastereomer 
ratio) as a colorless liquid.  
1H NMR (500 MHz, CDCl3, δ): 0.93 (t, J = 7.2 Hz, 1.8H), 0.94 (t, J = 7.2 Hz, 1.2H), 1.28–1.49 (m, 3H), 
1.55–1.66 (m, 1H), 1.78–2.02 (m, 2H), 3.01 (dd, J = 14.1, 4.3 Hz, 0.6H), 3.05–3.14 (m, 0.8H), 3.20 (br 
dd, J = 14.1, 4.3 Hz, 0.6H), 3.65–3.85 (m, 2H), 7.18–7.31 (m, 3H), 7.34 (d, J = 7.6 Hz, 0.6H), 7.43 (d, J 
= 7.6 Hz, 0.4H). 13C NMR (126 MHz, CDCl3, δ): 14.0, 14.0, 22.2 (q, JCF = 3 Hz), 22.3 (q, JCF = 3 Hz), 
22.3, 22.4, 29.9, 30.2, 35.0, 38.1, 41.9, 42.1, 42.4 (q, JCF = 26 Hz), 43.2 (q, JCF = 26 Hz), 126.3 (q, JCF = 
282 Hz), 126.6 (q, JCF = 282 Hz), 126.6, 126.8, 127.5, 127.9, 128.0, 128.7 (q, JCF = 1 Hz), 128.8, 129.2 (q, 
JCF = 1 Hz), 129.8 (q, JCF = 2 Hz), 130.6 (q, JCF = 2 Hz), 140.2, 140.8. 19F NMR (470 MHz, CDCl3, δF): 
95.4 (d, JFH = 9 Hz, 1.8F); 94.6 (d, JFH = 9 Hz, 1.2F). IR (neat): 3060, 3025, 2958, 2931, 1493, 1446, 1346, 
1273, 1244, 1238, 1151, 1107 cm-1. Anal. Calcd for C14H17F3S: C, 61.29; H, 6.25. Found: C, 61.41; H, 
6.43. 
4-Difluoromethylene-3,4-dihydro-1H-2-benzothiopyran (10a): To a solution of 6a (56 mg, 0.22 mmol) 
in THF (2.2 mL) was added NaOMe (24 mg, 0.43 mmol) at 0 °C. The reaction mixture was stirred at 
0 °C for 30 min and at room temperature for an additional 3 h. Then, phosphate buffer (pH 7) was added 
to quench the reaction. Organic materials were extracted with Et2O three times. The combined extracts 
were washed with brine and dried over Na2SO4. After removal of the solvent under reduced pressure, the 
residue was purified by PTLC (pentane–Et2O 20:1) to give 10a (32 mg, 76%) as a colorless liquid. 1H 
NMR (500 MHz, CDCl3, δ): 3.53 (dd, JHF = 2.3, 2.3 Hz, 2H), 3.79 (s, 2H), 7.16 (d, J = 7.4 Hz, 1H), 7.21 
(dd, J = 7.4, 7.4 Hz, 1H), 7.25 (dd, J = 7.4, 7.4 Hz, 1H), 7.50 (d, J = 7.4 Hz, 1H). 13C NMR (126 MHz, 
CDCl3, δ): 25.1 (dd, JCF = 2, 2 Hz), 30.8, 87.1 (dd, JCF = 23, 12 Hz), 127.0, 127.2, 127.9, 128.5 (dd, JCF = 
11, 1 Hz), 129.2 (dd, JCF = 5, 4 Hz), 135.2 (d, JCF = 5 Hz), 152.9 (dd, JCF = 297, 287 Hz). 19F NMR (470 
MHz, CDCl3, δF): 72.3 (d, JFF = 37 Hz, 1F), 75.1 (d, JFF = 37 Hz, 1F). IR (neat): 3064, 2910, 1712, 1489, 
1326, 1228, 1112, 985, 756, 713 cm-1. Anal. Calcd for C10H8F2S: C, 60.59; H, 4.07. Found: C, 60.38; H, 
4.15. 
1-Butyl-4-difluoromethylene-3,4-dihydro-1H-2-benzothiopyran (10b): Compound 10b was prepared 
by the method described for 10a. Purification by PTLC (pentane–Et2O 30:1) gave 10b (73%) as a 
colorless liquid. 1H NMR (500 MHz, CDCl3, δ): 0.91 (t, J = 7.1 Hz, 3H), 1.28–1.41 (m, 3H), 1.47–1.58 
(m, 1H), 1.77–1.88 (m, 2H), 3.46 (ddd, JHF = 14.1, 2.4, 2.4 Hz, 1H), 3.63 (ddd, JHF = 14.1, 2.4, 2.4 Hz, 
 
 
 
1H), 3.73 (t, J = 6.8 Hz, 1H), 7.15–7.18 (m, 1H), 7.21–7.27 (m, 2H), 7.43–7.47 (m, 1H). 13C NMR (126 
MHz, CDCl3, δ): 13.9, 22.3, 22.5, 30.1, 36.5, 43.6, 86.9 (dd, JCF = 23, 13 Hz), 126.8, 127.1, 127.3, 128.7, 
128.7 (d, JCF = 8 Hz), 140.5 (d, JCF = 5 Hz), 152.9 (dd, JCF = 296, 288 Hz). 19F NMR (470 MHz, CDCl3, 
δF): 71.3 (d, JFF = 37 Hz, 1F), 75.0 (d, JFF = 37 Hz, 1F). IR (neat): 3066, 2956, 2929, 2858, 1716, 1487, 
1254, 1232, 1106, 980, 758cm-1. Anal. Calcd for C14H16F2S: C, 66.11; H, 6.34. Found: C, 66.10; H, 6.52. 
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